May 10, 2023 / 05:00PM GMT
Tazeen Ahmad - BofA Securities, Research Division - MD in Equity Research & Research Analyst
Everybody, good morning. Thanks for joining us. Welcome to the Bank of America Healthcare Conference. I'm Tazeen Ahmad. I'm one of the senior SMID Biotech analysts here. It's my pleasure to have with us our next presenting company, Cerevel Therapeutics.
Presenting for Cerevel this morning is now outgoing CEO, Tony Coles. So I do have a list of questions. Maybe you can start off, Tony, by giving us an overview of the company. And then I guess, from those who didn't listen to the earnings call, talk to us about why you think now is the right time to transition the CEO seat. You'll still be with the company, of course, with the Board.
N. Anthony Coles - Cerevel Therapeutics Holdings, Inc. - Executive Chairman & CEO
As chair.
Questions and Answers:
Tazeen Ahmad - BofA Securities, Research Division - MD in Equity Research & Research AnalystHow do you envision your role at the company continuing going